Literature DB >> 3017641

Alveolitis of pulmonary asbestosis. Bronchoalveolar lavage studies in crocidolite- and chrysotile-exposed individuals.

B W Robinson, A H Rose, A James, D Whitaker, A W Musk.   

Abstract

Bronchoalveolar lavage (BAL) findings in 27 individuals with crocidolite- or chrysotile-induced asbestosis were compared to BAL findings in 29 unexposed control subjects. Alveolitis, defined as an increase in the proportions and/or absolute numbers of inflammatory cells present in BAL fluid compared to values in control subjects, was present in 26 (96 percent) subjects with asbestosis. Most exhibited a neutrophil-eosinophil alveolitis, with neutrophil proportions increased to 7.4 +/- 0.7 percent and eosinophil proportions increased to 2.2 +/- 0.4 percent, compared to 2 +/- 0.5 percent and 0.4 +/- 0.01 percent, respectively, in control subjects (p less than 0.01 for both neutrophils and eosinophils). An increase in the total number of neutrophils and eosinophils per ml of lavage fluid was also seen (neutrophils 23 +/- 5 and eosinophils 13 +/- 4 per ml; p less than 0.05 compared to control subjects). Severity of the alveolitis, defined by the neutrophil or eosinophil proportions, was independent of a history of exposure to cigarette smoke. The pattern and severity of alveolitis in crocidolite- and chrysotile-induced asbestosis were similar. There was a significant correlation between duration of exposure to asbestos and neutrophil proportions (p less than 0.01). No significant difference in the severity of the alveolitis was observed between individuals with radiologic and physiologic evidence of asbestosis compared to those with asbestos exposure and crackles alone, suggesting that, in asbestosis as in other chronic interstitial lung diseases, radiologic and physiologic parameters do not reflect the severity of the alveolitis. This study demonstrates that a neutrophil-eosinophil alveolitis is present in individuals with crocidolite- and chrysotile-induced asbestosis, that this alveolitis is independent of cigarette smoking, and that the severity of the BAL changes is not reflected in radiologic and physiologic changes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017641     DOI: 10.1378/chest.90.3.396

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Pulmonary gamma interferon production in patients with fibrosing alveolitis.

Authors:  B W Robinson; A H Rose
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

2.  Computed tomography in the early detection of asbestosis.

Authors:  R Bégin; G Ostiguy; R Filion; N Colman; P Bertrand
Journal:  Br J Ind Med       Date:  1993-08

3.  Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits.

Authors:  A M Boylan; C Rüegg; K J Kim; C A Hébert; J M Hoeffel; R Pytela; D Sheppard; I M Goldstein; V C Broaddus
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

4.  Bronchoalveolar neutrophilia inversely correlates with DLCO at diagnosis in asbestosis but not lung function decline at 1 year.

Authors:  Gareth Walters; Sushil Agarwal; Karanvir Singh; P Sherwood Burge; Emmet E McGrath
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

5.  Elevated interleukin-8 in the alveolitis of individuals with asbestos exposure.

Authors:  M Broser; Y Zhang; C Aston; T Harkin; W N Rom
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

Review 6.  Selected new developments in asbestos immunotoxicity.

Authors:  G J Rosenthal; E Corsini; P Simeonova
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

7.  The production of TNF-alpha and IL-1-like activity by bronchoalveolar leucocytes after intratracheal instillation of crocidolite asbestos.

Authors:  X Y Li; D Lamb; K Donaldson
Journal:  Int J Exp Pathol       Date:  1993-08       Impact factor: 1.925

8.  Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients.

Authors:  Katrin Schmidt; Lorena Martinez-Gamboa; Susan Meier; Christian Witt; Christian Meisel; Leif G Hanitsch; Mike O Becker; Doerte Huscher; Gerd R Burmester; Gabriela Riemekasten
Journal:  Arthritis Res Ther       Date:  2009-07-17       Impact factor: 5.156

Review 9.  Bronchoalveolar lavage.

Authors:  W R Martin; P A Padrid; C E Cross
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.